Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Synagis 50 mg/0.5 mL injection, 0.5 mL vial |
Is a |
True |
Synagis |
Inferred relationship |
Some |
|
Synagis 100 mg/mL injection, 1 mL vial |
has TP |
True |
Synagis |
Inferred relationship |
Some |
|
Synagis 50 mg/0.5 mL injection, 0.5 mL vial |
has TP |
True |
Synagis |
Inferred relationship |
Some |
|
Synagis 50 mg/0.5 mL injection, 0.5 mL vial |
has TP |
True |
Synagis |
Inferred relationship |
Some |
|
Synagis 100 mg/mL injection, vial |
Is a |
True |
Synagis |
Inferred relationship |
Some |
|
Synagis 100 mg/mL injection, 1 mL vial |
has TP |
True |
Synagis |
Inferred relationship |
Some |
|
Synagis (palivizumab 100 mg) powder for injection, 100 mg vial |
Is a |
True |
Synagis |
Inferred relationship |
Some |
|
Synagis (inert substance) diluent, 1 mL ampoule |
Is a |
True |
Synagis |
Inferred relationship |
Some |
|
Synagis (1 x 100 mg vial, 1 x 1 mL inert diluent ampoule), 1 pack |
has TP |
True |
Synagis |
Inferred relationship |
Some |
|
Synagis (palivizumab 50 mg) powder for injection, 50 mg vial |
Is a |
True |
Synagis |
Inferred relationship |
Some |
|
Synagis (1 x 50 mg vial, 1 x 1 mL inert diluent ampoule), 1 pack |
has TP |
True |
Synagis |
Inferred relationship |
Some |
|
Synagis (inert substance) diluent [1 x 1 mL ampoule] (&) (palivizumab 100 mg) powder for injection [1 x 100 mg vial], 1 pack (containered trade product pack) |
has TP |
True |
Synagis |
Inferred relationship |
Some |
|
Synagis (inert substance) diluent [1 x 1 mL ampoule] (&) (palivizumab 50 mg) powder for injection [1 x 50 mg vial], 1 pack (containered trade product pack) |
has TP |
True |
Synagis |
Inferred relationship |
Some |
|